子宫腺肌病
医学
子宫内膜异位症
宫腔镜检查
子宫切除术
盆腔疼痛
不育
相伴的
放射性武器
子宫
妇科
外科
产科
怀孕
内科学
生物
遗传学
作者
Tommaso Capezzuoli,Federico Toscano,Marcello Ceccaroni,Giovanni Roviglione,Anna Stepniewska,Massimiliano Fambrini,Silvia Vannuccini,Felice Petraglia
标识
DOI:10.1016/j.bpobgyn.2024.102507
摘要
Adenomyosis is a common benign uterine disorders and patients may present dysmenorrhea, dyspareunia, abnormal uterine bleeding (AUB) and infertility. The treatment is very complex, including medical, surgical or radiological approaches. Hormonal drugs represent the first line therapy of adenomyosis, highly effective on symptoms and uterine volume reduction. Radiological procedures (UAE and HIFU), RFA and hysteroscopy may be proposed in those cases in which medical therapy is ineffective. Considering surgical treatment, hysterectomy remains the only existing definitive treatment but in the last decades the desire of uterus preservation is becoming more and more diffuse. On the other hand, surgical conservative treatments of adenomyosis are very effective in ameliorating AUB and pelvic pain and in reducing uterine volume, with some post-operative risks and obstetrics complications. Cytoreductive surgery for adenomyosis may be very complex, therefore it should be performed by experienced surgeons in dedicated centers, above all in case of concomitant endometriosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI